Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Increase (Decrease) in Due to Related Parties

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Increase (Decrease) in Due to Related Parties

Insight Molecular Diagnostics Inc. (IMDX) reported Increase (Decrease) in Due to Related Parties of -$6.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-19.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2021-11-09

  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for the quarter ending 2020-09-30 was $0.00.
  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for the quarter ending 2020-03-31 was -$6.00K.
  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for fiscal 2020 was -$6.00K.
  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for fiscal 2019 was -$2.09M, a 104800.00% decline from fiscal 2018.
  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for fiscal 2018 was $2.00K.
  • Insight Molecular Diagnostics Inc. increase (decrease) in due to related parties for fiscal 2017 was -$753.00K, a 137.52% decline from fiscal 2016.
Period endIncrease (Decrease) in Due to Related Parties 3 monthIncrease (Decrease) in Due to Related Parties 3 month as first filedIncrease (Decrease) in Due to Related Parties 6 monthIncrease (Decrease) in Due to Related Parties 6 month as first filedIncrease (Decrease) in Due to Related Parties 9 monthIncrease (Decrease) in Due to Related Parties 9 month as first filedIncrease (Decrease) in Due to Related Parties 12 monthIncrease (Decrease) in Due to Related Parties 12 month as first filed
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
$0.00
derived: sum of 2 quarters · filed 2021-11-09
$0.00
derived: sum of 3 quarters · filed 2021-11-09
-$6.00K
10-K · filed 2021-03-19
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$0.00
derived: sum of 2 quarters · filed 2021-11-09
-$6.00K
10-Q · filed 2021-11-09
$0.00
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$6.00K
10-Q · filed 2021-08-11
$0.00
derived: sum of 3 quarters · filed 2021-08-11
-$4.00K
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31-$6.00K
10-Q · filed 2021-05-17
$0.00
derived: sum of 2 quarters · filed 2021-05-17
-$4.00K
derived: sum of 3 quarters · filed 2021-05-17
$1.00K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
$2.00K
derived: sum of 2 quarters · filed 2021-03-19
$7.00K
derived: sum of 3 quarters · filed 2021-03-19
-$2.09M
10-K · filed 2021-03-19
2019-09-30-$4.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$1.00K
derived: sum of 2 quarters · filed 2020-11-12
-$2.10M
10-Q · filed 2020-11-12
-$2.11M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
-$2.10M
10-Q · filed 2020-07-29
-$2.11M
derived: sum of 3 quarters · filed 2020-07-29
-$2.10M
derived: sum of 4 quarters · filed 2020-07-29
2019-03-31-$2.10M
10-Q · filed 2020-05-12
-$2.11M
derived: sum of 2 quarters · filed 2020-05-12
-$2.10M
derived: sum of 3 quarters · filed 2020-05-12
-$2.11M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31-$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$1.00K
derived: sum of 2 quarters · filed 2020-03-26
-$5.00K
derived: sum of 3 quarters · filed 2020-03-26
$2.00K
10-K · filed 2020-03-26
2018-09-30$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$5.00K
derived: sum of 2 quarters · filed 2019-11-14
$12.00K
10-Q · filed 2019-11-14
$9.00K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.00K
10-Q · filed 2019-08-14
-$2.00K
derived: sum of 3 quarters · filed 2019-08-14
-$439.00K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$7.00K
10-Q · filed 2019-05-14
$4.00K
derived: sum of 2 quarters · filed 2019-05-14
-$433.00K
derived: sum of 3 quarters · filed 2019-05-14
-$502.00K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$440.00K
derived: sum of 2 quarters · filed 2019-04-01
-$509.00K
derived: sum of 3 quarters · filed 2019-04-01
-$753.00K
10-K · filed 2019-04-01
2017-09-30-$437.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$506.00K
derived: sum of 2 quarters · filed 2018-11-13
-$750.00K
10-Q · filed 2018-11-13
-$153.00K
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$69.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
-$313.00K
10-Q · filed 2018-08-14
$284.00K
derived: sum of 3 quarters · filed 2018-08-14
$702.00K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$244.00K
10-Q · filed 2018-05-15
$353.00K
derived: sum of 2 quarters · filed 2018-05-15
$771.00K
derived: sum of 3 quarters · filed 2018-05-15
$1.14M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$597.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$1.01M
derived: sum of 2 quarters · filed 2018-04-02
$1.38M
derived: sum of 3 quarters · filed 2018-04-02
$2.01M
10-K · filed 2018-04-02
$1.90M
10-K · filed 2017-02-27
2016-09-30$418.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$786.00K
derived: sum of 2 quarters · filed 2017-11-14
$1.41M
10-Q · filed 2017-11-14
$1.30M
10-Q · filed 2016-11-10
$1.68M
derived: sum of 4 quarters · filed 2018-04-02
2016-06-30$368.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$992.00K
10-Q · filed 2017-08-14
$881.00K
10-Q · filed 2016-08-11
$1.26M
derived: sum of 3 quarters · filed 2018-04-02
$1.18M
derived: sum of 4 quarters · filed 2018-04-02
2016-03-31$624.00K
10-Q · filed 2017-04-28
$511.00K
10-Q · filed 2016-05-16
$891.00K
derived: sum of 2 quarters · filed 2018-04-02
$808.00K
derived: sum of 3 quarters · filed 2018-04-02
$1.13M
derived: sum of 4 quarters · filed 2018-04-02
2015-12-31$267.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$184.00K
derived: sum of 2 quarters · filed 2018-04-02
$510.00K
derived: sum of 3 quarters · filed 2018-04-02
$1.56M
10-K · filed 2018-04-02
$1.67M
10-K · filed 2017-02-27
2015-09-30-$83.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$243.00K
derived: sum of 2 quarters · filed 2016-11-10
$1.29M
10-Q · filed 2016-11-10
2015-06-30$326.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$1.37M
10-Q · filed 2016-08-11
2015-03-31$1.05M
10-Q · filed 2016-05-16
2014-12-31$2.82M
10-K · filed 2017-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92